Northwest Bio Provides Update On DCVax®-L Brain Cancer Trial 
MarketWatch (press release)
... (NW Bio) announced today that it now has 41 clinical trial sites open and recruiting across the United States in its ongoing clinical trial of DCVax®-L immune therapy for Glioblastoma multiforme (GBM), the most lethal form of brain cancer.

and more » 

Team Billy Ride and Walk to support brain cancer research Saturday 
Albany Times Union (blog)
Held in honor of Billy Grey, who died of glioblastoma multiforme on July 13, 2001, just short of his 13th birthday, the event has raised nearly $60000 over the yeras. .The Billy Grey Research Chair is administered through the National Brain Tumor ...

and more » 

Vaccine Extends Survival in Recurrent Glioblastoma 
Medscape
May 3, 2012 (Miami, Florida) ? In a multicenter clinical trial of an autologous heat-shock protein-peptide vaccine, patients with recurrent glioblastoma multiforme (GBM) who received the vaccine survived longer than comparable historical control ...

 

The treatment of glioblastoma multiforme through activation of microglia and ... 
7thSpace Interactive (press release)
We examined the effect of intra-cranially administered recombinant adeno-associated virus encoding interleukin-12 (rAAV2/IL12) on transfection efficiency, local immune activity and survival in a rat model of glioblastoma multiforme.

 

New treatment for brain cancer could extend life by two years 
Evening Standard
About 13000 people are diagnosed with brain cancer in the UK every year, with about half diagnosed with the most common and aggressive type, known as glioblastoma multiforme. The tumour is currently treated with drugs and surgery but the survival time ...

and more » 

David Martin Pearson 
The Free Lance-Star
David Martin Pearson, 18, was called home to the Lord on Friday, May 11, 2012, at his home in Fredericksburg, after a 20-month battle with glioblastoma multiforme, an aggressive form of brain cancer. He is survived by his father, Mark Steven Pearson, ...

and more » 

Brain Tumor Vaccine Shows Promise 
Cancer Network
By Anna Azvolinsky, PhD | April 24, 2012 Results from a phase II clinical trial with HSPPC-96 (vitespen), an autologous heat shock protein-peptide vaccine, have shown promise in patients with recurrent glioblastoma multiforme.
Vaccinations: Not just for disease prevention anymore Fox News

all 2 news articles » 

Tested: Pastor leans on faith during cancer diagnosis 
The Times and Democrat
Don Smoak, pastor of Fellowship Baptist Church, has relied on his faith throughout his battle with glioblastoma multiforme. A local pastor is practicing what he preaches: faith. What initially started out as a routine sinus problem eventually resulted ...

and more » 

Copper compound induces autophagy and apoptosis of glioma cells by reactive ... 
7thSpace Interactive (press release)
Glioblastoma multiforme (GBM) is the most aggressive of the primary brain tumors, with a grim prognosis despite intensive treatment. In the past decades, progress in research has not significantly increased overall survival rate.

 

ImmunoCellular Provides an Update on Enrollment for the Company's Phase II ... 
MarketWatch (press release)
... on clinical trial site activity and patient enrollment for its Phase II clinical trial of ICT-107, the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
ImmunoCellular expects to complete phase II cancer vaccine enrollment in Q2 Proactive Investors USA & Canada
QualityStocks News - ImmunoCellular Therapeutics Updates on Clinical Activity ... DigitalJournal.com (press release)
ImmunoCellular Therapeutics (IMUC) Provides Update on Enrollment for Phase II ... Tech24

all 15 news articles »